<?xml version="1.0" encoding="UTF-8"?>
<p>The liver biopsy of a patient with COVID-19 also showed steatosis and liver injury [
 <xref rid="B30-medicina-56-00386" ref-type="bibr">30</xref>]. The infection with COVID-19 and the development of the disease are accompanied by the presence of many hepatic alterations, which may result from the effect of the virus on the liver or from side effects of the medications [
 <xref rid="B31-medicina-56-00386" ref-type="bibr">31</xref>]. In addition, liver injury may also result from immune-mediated inflammation, with a cytokine storm and pneumonia-associated hypoxia. This may also lead to liver failure in critically ill patients with COVID-19 [
 <xref rid="B29-medicina-56-00386" ref-type="bibr">29</xref>].
</p>
